If you are having trouble viewing this email, click here

Sponsored by

March 25, 2016

Billerica maker of lead diagnostic test Magellan acquired by Meridian for $66M

Earlier this year, the 60-employee company made about two dozen of its LeadCare II tests available to help families in the Flint, Michigan area.

Summit develops a unique Duchenne drug for any gene mutation

The U.K.-based company opened a Cambridge office two years ago, just a few blocks away from its better-known colleague in the Duchenne space, Sarepta Therapeutics.

Forum Pharma announces restructuring, late-stage trial failure

The formal announcement came less than two hours after the Boston Business Journal reported yesterday that the Waltham firm had already notified the state about planned layoffs.

Number of newborns addicted to opioids skyrockets in Massachusetts

As the opioid epidemic rages on in Massachusetts, the state is taking stock of a new victim: newborns.

Boston Business Journal Science & Tech Newsletters
Subscribe to additional BBJ Newsletters in Science, Tech and Venture Capital

Don Seiffert

BioFlash Editor

dseiffert@bizjournals.com

617-316-3271

Connect with us

News from the BBJ

As Partners deal hangs in limbo, Emerson Hospital makes independence work

GE CEO Jeff Immelt on Boston's startup culture: 'It's astounding'

National Technology News

Meet, treat, grow: UCSF 'Sandler model' pushes neurosciences expansion

Main Line research team develops potential new approach to treating ovarian cancer

Cancel Email Subscription

You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/

If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202

The Business Journals | Latest News | Advertise | Contact Info | Subscribe to Print Edition

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.